Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome
Clinical trial NCT04655599 · TERMINATED
Trial details
- NCT number
- NCT04655599
- Sponsor
- Arena Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-29
- Primary completion
- 2021-04-13
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.